News Madrigal Pharmaceuticals Appoints Bill Sibold as Chief Executive Officer Staff September 11, 2023 Iframe sync Post navigation Previous: Marker Therapeutics Announces Complete Response in First Lymphoma Patient Treated with MT-601 after CAR T RelapseNext: EyePoint Pharmaceuticals Reports Positive Masked Safety Update for Lead Product Candidate EYP-1901 in Ongoing PAVIA and DAVIO 2 Phase 2 Clinical Trials as of September 1, 2023 More Stories Healthcare Medicaid Medicare News Nutrition Pharmaceutical CV Sciences, Inc. Positioned to Participate in the Medicare and Medicaid Pilot Program for CBD Staff December 22, 2025 Diagnostics Fitness News Private Wellness Club Continuum Unlocks Final Membership Tier at West Village Flagship Staff December 22, 2025 Cancer Diagnostics DNA News Ginkgo Bioworks Partners with Carnegie-Mellon University to Develop Innovative New Cancer Screening Approach Staff December 22, 2025
